Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGILENT TECHNOLOGIES, INC.A · Entity 3062 | Director · CEO and President | March 08, 2024 | March 12, 2024 |
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | Director | September 30, 2026 | October 03, 2026 |
| KLA CORPKLAC · Entity 2838 | Director | November 05, 2025 | November 07, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGILENT TECHNOLOGIES, INC.
Report date March 08, 2024 · Filed March 12, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 253,908.5436 |
Reported balance
After 2024-03-08 transaction · row 1
1 source rowRow 1 · 2024-03-08 · Sale · Disposed 52,297 · Balance 253,908.5436 F1: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 30, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 30, 2023.
BRISTOL MYERS SQUIBB CO
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 17,050.601 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 560.897 · Balance 17,050.601 F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.
KLA CORP
Report date November 05, 2025 · Filed November 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,178.732 |
Reported balance
After 2025-11-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-11-05 · Grant · Acquired 203.732 · Balance 1,178.732 F1: On November 5, 2025, the Reporting Person received an automatic grant of restricted stock units ("RSUs") for 203.732 shares of KLA common stock. The RSUs vest on the earliest to occur of (i) November 5, 2026, (ii) immediately prior to the next annual meeting of stockholders, and (iii) ten days prior to a change of control of KLA. F2: The number of shares of KLA common stock includes 203.732 shares issuable upon vesting of RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 5, 2025, the Reporting Person received an automatic grant of restricted stock units ("RSUs") for 203.732 shares of KLA common stock. The RSUs vest on the earliest to occur of (i) November 5, 2026, (ii) immediately prior to the next annual meeting of stockholders, and (iii) ten days prior to a change of control of KLA.
F2: The number of shares of KLA common stock includes 203.732 shares issuable upon vesting of RSUs.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
COHERENT INC
Report date July 01, 2022 · Filed July 01, 2022
Section 16 reporting ended · disclosed 2022-07-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-07-01 transaction · row 1
1 source rowRow 1 · 2022-07-01 · Disposition to issuer · Disposed 6,043 · Balance 0 F1: On July 1, 2022, II-VI Incorporated ("Buyer"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Watson Merger Sub Inc, a direct, wholly owned subsidiary of Buyer ("Merger Sub"), dated as of March 25, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger (the "Merger"). F2: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $220.00 in cash, without interest (the "Cash Consideration"), plus 0.91 of a validly issued, fully paid and nonassessable share of Buyer (the "Merger Consideration"). |
Filing footnotes · ownership attribution and instrument terms
F1: On July 1, 2022, II-VI Incorporated ("Buyer"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Watson Merger Sub Inc, a direct, wholly owned subsidiary of Buyer ("Merger Sub"), dated as of March 25, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger (the "Merger").
F2: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $220.00 in cash, without interest (the "Cash Consideration"), plus 0.91 of a validly issued, fully paid and nonassessable share of Buyer (the "Merger Consideration").
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:23 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 560.897 | $62.40 | $34,999.97 |
DisclosureSEC source: 0001418949-26-000010 · wk-form4_1790972595.xml · derivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,050.601 Underlying: Common Stock, $0.10 par value · 560.897 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 607.428 | $57.62 | $35,000.00 |
DisclosureSEC source: 0001418949-26-000008 · wk-form4_1783023386.xml · derivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,332.54 Underlying: Common Stock, $0.10 par value · 607.428 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:25 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 577.082 | $60.65 | $35,000.02 |
DisclosureSEC source: 0001418949-26-000006 · wk-form4_1775161506.xml · derivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,556.771 Underlying: Common Stock, $0.10 par value · 577.082 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:27 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 3,996.367 | $55.05 | $220,000.00 |
DisclosureSEC source: 0001418949-26-000004 · wk-form4_1770154029.xml · derivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,979.689 Underlying: Common Stock, $0.10 par value · 3,996.367 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 648.869 | $0.00 | $0.00 |
DisclosureSEC source: 0001418949-26-000002 · wk-form4_1767647563.xml · derivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,860.897 Underlying: Common Stock, $0.10 par value · 648.869 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 21:05 UTC | KLA CORP KLAC · Entity 2838 | GrantCommon Stock | 203.732 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-272314 · ownership.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,178.732 F1 · shares: On November 5, 2025, the Reporting Person received an automatic grant of restricted stock units ("RSUs") for 203.732 shares of KLA common stock. The RSUs vest on the earliest to occur of (i) November 5, 2026, (ii) immediately prior to the next annual meeting of stockholders, and (iii) ten days prior to a change of control of KLA. F2 · balance_after: The number of shares of KLA common stock includes 203.732 shares issuable upon vesting of RSUs. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 22:14 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 776.053 | $0.00 | $0.00 |
DisclosureSEC source: 0001418949-25-000007 · wk-form4_1759443242.xml · derivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,076.278 Underlying: Common Stock, $0.10 par value · 776.053 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 21:50 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 728.359 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000123 · wk-form4_1751406620.xml · derivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,171.659 Underlying: Common Stock, $0.10 par value · 728.359 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 21:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 512.379 | $60.99 | $31,250.00 |
DisclosureSEC source: 0000014272-25-000079 · wk-form4_1743544782.xml · derivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,339.083 Underlying: Common Stock, $0.10 par value · 512.379 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · price: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. Read SEC document |
| February 01, 2025 Filed Feb 5, 2025 00:18 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 3,562.341 | $58.95 | $210,000.00 |
DisclosureSEC source: 0000014272-25-000024 · wk-form4_1738714686.xml · derivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,826.704 Underlying: Common Stock, $0.10 par value · 3,562.341 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 23:27 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 552.511 | $56.56 | $31,250.02 |
DisclosureSEC source: 0000014272-25-000004 · wk-form4_1735860431.xml · derivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,220.713 Underlying: Common Stock, $0.10 par value · 552.511 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:05 UTC | KLA CORP KLAC · Entity 2838 | GrantCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-124053 · ownership.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 975 F1 · shares: On November 6, 2024, the Reporting Person received an automatic grant of restricted stock units ("RSUs") for 350 shares of KLA common stock. The RSUs vest on the earliest to occur of (i) November 6, 2025, (ii) immediately prior to the next annual meeting of stockholders, and (iii) ten days prior to a change of control of KLA. F2 · balance_after: The number of shares of KLA common stock includes 350 shares issuable upon vesting of RSUs. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 21:42 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 603.981 | $51.74 | $31,249.98 |
DisclosureSEC source: 0000014272-24-000135 · wk-form4_1727905324.xml · derivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,628.127 Underlying: Common Stock, $0.10 par value · 603.981 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 00:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCall Option (obligation to sell) · Derivative | 5 | $0.00 Strike: $46.00 | $0.00 |
DisclosureSEC source: 0000014272-24-000127 · wk-form4_1722471151.xml · derivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Family Trust Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 500 shares Expires 2024-08-16 F1 · kind: Prior to the reporting person joining the Board of Directors of Bristol-Myers Squibb Company, the family trust of the reporting person wrote five covered call options with respect to a total of 500 shares of common stock beneficially owned by the reporting person and held in a managed account. On July 29, 2024, the family trust of the reporting person cancelled these call options by purchasing five identical call options at a price of $3.85 per underlying share, thus closing the option position. F2 · ownership.nature: Securities held in a family trust, where reporting person is the trustee and a beneficiary. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 21:34 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 2,986.941 | $41.30 | $123,360.66 |
DisclosureSEC source: 0000014272-24-000118 · wk-form4_1719956062.xml · derivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,986.941 Underlying: Common Stock, $0.10 par value · 2,986.941 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · shares: Represents pro rata portion of the 2024 annual Deferred Share Unit awards granted to the Company's directors. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 18:37 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | SaleCommon Stock | 52,297 | $150.00 | $7,844,550.00 |
DisclosureSEC source: 0001127602-24-009663 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 253,908.5436 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 30, 2023. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:08 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,751 | $0.00 Strike: $42.12 | $0.00 |
DisclosureSEC source: 0001127602-23-029728 · form4.xml · derivative · entry 3 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,751 shares Expires 2025-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:08 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | SaleCommon Stock | 2,751 | $130.00 | $357,630.00 |
DisclosureSEC source: 0001127602-23-029728 · form4.xml · nonDerivative · entry 2 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 306,205.5436 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 30, 2023. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:08 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionCommon Stock | 2,751 | $42.12 | $115,872.12 |
DisclosureSEC source: 0001127602-23-029728 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 308,956.5436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2023 Filed Dec 8, 2023 19:59 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 62,467 | $0.00 Strike: $42.12 | $0.00 |
DisclosureSEC source: 0001127602-23-029122 · form4.xml · derivative · entry 3 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,751 Underlying: Common Stock · 62,467 shares Expires 2025-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| December 07, 2023 Filed Dec 8, 2023 19:59 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | SaleCommon Stock | 62,467 | $130.00 | $8,120,710.00 |
DisclosureSEC source: 0001127602-23-029122 · form4.xml · nonDerivative · entry 2 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 306,205.5436 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 30, 2023. Read SEC document |
| December 07, 2023 Filed Dec 8, 2023 19:59 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionCommon Stock | 62,467 | $42.12 | $2,631,110.04 |
DisclosureSEC source: 0001127602-23-029122 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 368,672.5436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2023 Filed Dec 8, 2023 16:58 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantEmployee Stock Option (Right to Buy) · Derivative | 71,449 | $123.99 Strike: $123.99 | $8,858,961.51 |
DisclosureSEC source: 0001127602-23-029108 · form4.xml · derivative · entry 2 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,449 Underlying: Common Stock · 71,449 shares Expires 2033-11-22 F2 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. F3 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated. Read SEC document |
| November 22, 2023 Filed Dec 8, 2023 16:58 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 25,195 | $123.99 | $3,123,928.05 |
DisclosureSEC source: 0001127602-23-029108 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,205.5436 F1 · shares: Restricted Stock Units granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on November 22, 2023 and are subject to a 1-year post-vest holding period. Read SEC document |
| November 17, 2023 Filed Nov 20, 2023 23:06 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 10,206 | $113.15 | $1,154,808.90 |
DisclosureSEC source: 0001127602-23-028020 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,010.5436 F1 · shares: The reporting person surrendered 10,206 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 17:14 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 2,013 | $114.19 | $229,864.47 |
DisclosureSEC source: 0001127602-23-027949 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,216.5436 F1 · shares: The reporting person surrendered 2,013 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 18:33 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 2,510 | $113.60 | $285,136.00 |
DisclosureSEC source: 0001127602-23-027750 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,229.5436 F1 · shares: The reporting person surrendered 2,510 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 14, 2023 Filed Nov 17, 2023 15:47 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 31,877 | $111.61 | $3,557,791.97 |
DisclosureSEC source: 0001127602-23-027713 · form4.xml · nonDerivative · entry 2 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,739.5436 F2 · shares: The reporting person surrendered 31,877 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 14, 2023 Filed Nov 17, 2023 15:47 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 66,748 | $111.61 | $7,449,744.28 |
DisclosureSEC source: 0001127602-23-027713 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,616.5436 F1 · shares: On November 14, 2023, 66,748 shares of common stock of Agilent Technologies, Inc. were issued to the reporting person pursuant to the Agilent Technologies, Inc. Long-Term Performance Program. The shares are subject to a 1-year post-vest holding period. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 20:05 UTC | KLA CORP KLAC · Entity 2838 | GrantCommon Stock | 493 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-058805 · ownership.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625 F1 · shares: On November 1, 2023, the Reporting Person received an automatic grant of restricted stock units ("RSUs") for 493 shares of KLA common stock. The RSUs vest on the earliest to occur of (i) November 1, 2024, (ii) immediately prior to the next annual meeting of stockholders, and (iii) ten days prior to a change of control of KLA. F2 · balance_after: The number of shares of KLA common stock includes 493 shares issuable upon vesting of RSUs. Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 19:03 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 944 | $0.00 Strike: $42.12 | $0.00 |
DisclosureSEC source: 0001127602-23-021558 · form4.xml · derivative · entry 3 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,218 Underlying: Common Stock · 944 shares Expires 2025-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 19:03 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | SaleCommon Stock | 944 | $130.00 | $122,720.00 |
DisclosureSEC source: 0001127602-23-021558 · form4.xml · nonDerivative · entry 2 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 260,868.5436 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 30, 2023. Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 19:03 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionCommon Stock | 944 | $42.12 | $39,761.28 |
DisclosureSEC source: 0001127602-23-021558 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 261,812.5436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 177.4435 shares acquired in an Employee Stock Purchase Plan under Section 423 of the Internal Revenue Code of 1986, as amended, in a transaction exempt under Rule 16b-3. Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 20:10 UTC | KLA CORP KLAC · Entity 2838 | GrantCommon Stock | 132 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-043407 · doc4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132 F1 · shares: On July 24, 2023, the Reporting Person received a pro-rated annual outside director grant of restricted stock units ("RSUs") for 132 shares of KLA common stock. The RSUs vest on the earliest to occur of (i) November 2, 2023, (ii) immediately prior to the next annual meeting of stockholders, and (iii) ten days prior to a change of control of KLA. F2 · balance_after: The number of shares of KLA common stock includes 132 shares issuable upon vesting of RSUs. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 18:53 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 128,726 | $0.00 Strike: $40.80 | $0.00 |
DisclosureSEC source: 0001127602-22-026322 · form4.xml · derivative · entry 3 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 128,726 shares Expires 2024-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 18:53 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | SaleCommon Stock | 128,726 | $155.73 | $20,046,499.98 |
DisclosureSEC source: 0001127602-22-026322 · form4.xml · nonDerivative · entry 2 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,691.1001 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 14, 2022. F2 · price: The average weighted sale price was $155.73 with a range of $153.00 - $157.43. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 18:53 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionCommon Stock | 128,726 | $40.80 | $5,252,020.80 |
DisclosureSEC source: 0001127602-22-026322 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,417.1001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 18:57 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 7,492 | $146.19 | $1,095,255.48 |
DisclosureSEC source: 0001127602-22-026141 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,691.1001 F1 · shares: The reporting person surrendered 7,492 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 15:55 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 2,713 | $144.44 | $391,865.72 |
DisclosureSEC source: 0001127602-22-026120 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,183.1001 F1 · shares: The reporting person surrendered 2,713 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 20:03 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,775 | $0.00 Strike: $40.80 | $0.00 |
DisclosureSEC source: 0001127602-22-026028 · form4.xml · derivative · entry 3 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,726 Underlying: Common Stock · 6,775 shares Expires 2024-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 20:03 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | SaleCommon Stock | 6,775 | $148.19 | $1,003,987.25 |
DisclosureSEC source: 0001127602-22-026028 · form4.xml · nonDerivative · entry 2 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,896.1001 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 14, 2022. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 20:03 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionCommon Stock | 6,775 | $40.80 | $276,420.00 |
DisclosureSEC source: 0001127602-22-026028 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,671.1001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 19:50 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 2,013 | $147.12 | $296,152.56 |
DisclosureSEC source: 0001127602-22-026023 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,896.1001 F1 · shares: The reporting person surrendered 2,013 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 14:47 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantEmployee Stock Option (Right to Buy) · Derivative | 59,165 | $148.00 Strike: $148.00 | $8,756,420.00 |
DisclosureSEC source: 0001127602-22-025886 · form4.xml · derivative · entry 4 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,165 Underlying: Common Stock · 59,165 shares Expires 2032-11-15 F4 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. F5 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 14:47 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 68,195 | $148.00 | $10,092,860.00 |
DisclosureSEC source: 0001127602-22-025886 · form4.xml · nonDerivative · entry 3 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,909.1001 F3 · shares: The reporting person surrendered 68,195 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 14:47 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 137,544 | $148.00 | $20,356,512.00 |
DisclosureSEC source: 0001127602-22-025886 · form4.xml · nonDerivative · entry 2 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,104.1001 F2 · shares: On November 15, 2022, 137,544 shares of common stock of Agilent Technologies, Inc. were issued to the reporting person pursuant to the Agilent Technologies, Inc. Long-Term Performance Program. The shares are subject to a 1 year post-vest holding period. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 14:47 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 20,245 | $148.00 | $2,996,260.00 |
DisclosureSEC source: 0001127602-22-025886 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,560.1001 F1 · shares: Restricted Stock Units granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on November 15, 2022 and are subject to a 1 year post-vest holding period. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 22:44 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 8,043 | $148.31 | $1,192,857.33 |
DisclosureSEC source: 0001127602-22-025644 · form4.xml · nonDerivative · entry 1 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,315.1001 F1 · shares: The reporting person surrendered 8,043 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 20:41 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,775 | $0.00 Strike: $40.80 | $0.00 |
DisclosureSEC source: 0001127602-22-025258 · form4.xml · derivative · entry 3 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,501 Underlying: Common Stock · 6,775 shares Expires 2024-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 20:41 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | SaleCommon Stock | 6,775 | $138.31 | $937,050.25 |
DisclosureSEC source: 0001127602-22-025258 · form4.xml · nonDerivative · entry 2 McMullen Michael R. · CIK 0001418949 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,358.1001 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 14, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.